|
|
viral life cycle
|
GO:0019058 |
132 |
0.936
|
|
|
|
regulation of viral genome replication
|
GO:0045069 |
48 |
0.896
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.784
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.781
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.774
|
|
|
|
viral genome replication
|
GO:0019079 |
50 |
0.758
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.720
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.704
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.685
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.668
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.586
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.457
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.377
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
35 |
0.316
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.297
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.272
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.219
|
Human |
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.215
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.214
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.212
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.209
|
|
|
|
response to interferon alpha
|
GO:0035455 |
11 |
0.204
|
|
|
|
glycosylation
|
GO:0070085 |
71 |
0.204
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.203
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.193
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.182
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.181
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.176
|
|
|
|
protein lipidation
|
GO:0006497 |
33 |
0.152
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.150
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.127
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.122
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.115
|
|
|
|
protein myristoylation
|
GO:0018377 |
1 |
0.113
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.109
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.098
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.087
|
Human |
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.085
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.084
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.084
|
Human |
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.080
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.078
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
42 |
0.071
|
|
|
|
glucose metabolic process
|
GO:0006006 |
45 |
0.066
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
4 |
0.063
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.062
|
|
|
|
regulation of nuclease activity
|
GO:0032069 |
11 |
0.058
|
|
|
|
multi organism localization
|
GO:1902579 |
14 |
0.057
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.055
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.055
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.055
|
|
|
|
regulation of ribonuclease activity
|
GO:0060700 |
3 |
0.053
|
|
|
|
response to dsrna
|
GO:0043331 |
25 |
0.053
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.052
|
|
|
|
protein glycosylation
|
GO:0006486 |
62 |
0.052
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.051
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.050
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
12 |
0.050
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.049
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.047
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.046
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.044
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
33 |
0.044
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.043
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.043
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.043
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.041
|
Human |
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.041
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.041
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
63 |
0.035
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.034
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.033
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.033
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.033
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.033
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.033
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.033
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.033
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.032
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.032
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.031
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.030
|
|
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.030
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
25 |
0.029
|
|
|
|
viral transcription
|
GO:0019083 |
35 |
0.029
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.028
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.028
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.028
|
|
|
|
intracellular transport of viral protein in host cell
|
GO:0019060 |
4 |
0.028
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.027
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.027
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.026
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.026
|
|
|
|
entry into host
|
GO:0044409 |
25 |
0.026
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.025
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.025
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.025
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.025
|
Human |
|
|
response to interferon beta
|
GO:0035456 |
11 |
0.025
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.024
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.024
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.023
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.023
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.023
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.023
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.023
|
|
|
|
response to type i interferon
|
GO:0034340 |
14 |
0.022
|
|
|
|
ncrna processing
|
GO:0034470 |
83 |
0.022
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.022
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.022
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.021
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.021
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.020
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.020
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.020
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.019
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.019
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.019
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.019
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.019
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.019
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.019
|
Human |
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.018
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.018
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.018
|
|
|
|
multi organism intracellular transport
|
GO:1902583 |
14 |
0.018
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.018
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.018
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.017
|
|
|
|
catecholamine secretion
|
GO:0050432 |
1 |
0.017
|
|
|
|
viral gene expression
|
GO:0019080 |
35 |
0.017
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.017
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.017
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
25 |
0.017
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.017
|
|
|
|
cytidine deamination
|
GO:0009972 |
7 |
0.016
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.016
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.016
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.016
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.016
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.016
|
|
|
|
negative regulation of defense response to virus by host
|
GO:0050689 |
4 |
0.015
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.015
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
11 |
0.015
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.015
|
|
|
|
negative regulation of mitochondrial depolarization
|
GO:0051902 |
2 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.014
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.014
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.014
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.014
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.014
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.014
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.014
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.014
|
|
|
|
epinephrine secretion
|
GO:0048242 |
1 |
0.014
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.014
|
|
|
|
cellular response to dsrna
|
GO:0071359 |
19 |
0.014
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.014
|
|
|
|
rna modification
|
GO:0009451 |
27 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.014
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.014
|
|
|
|
growth
|
GO:0040007 |
202 |
0.013
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.013
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.013
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.013
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
11 |
0.013
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.013
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.013
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.013
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.013
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.013
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
22 |
0.013
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.012
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.012
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.012
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.012
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.012
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.012
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.012
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.012
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.012
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.012
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.012
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.012
|
Human |
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.011
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.011
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.011
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.011
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.011
|
Human |
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.011
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.011
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.011
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
31 |
0.011
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.011
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.011
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.011
|
|
|
|
nuclear export
|
GO:0051168 |
69 |
0.011
|
Human |
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.011
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.011
|
Human |
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.011
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.011
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.011
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.011
|
Human |
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
25 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.010
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.010
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.010
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.010
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.010
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.010
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.010
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.010
|
|
|
|
entry into host cell
|
GO:0030260 |
25 |
0.010
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.010
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.010
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.010
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.010
|
|